Mirabegron for overactive bladder: Added benefit not proven

Important data on morbidity are missing, no advantages in mortality, morbidity and quality of life

2014-09-02

(Press-News.org) Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

Mirabegron had an advantage with regard to side effects: Dry mouth was less common in comparison with tolterodine. No added benefit could be determined for the outcomes "mortality", "morbidity" and "quality of life". As the drug manufacturer dossier contained no analyses for the total population on the patient-relevant morbidity criteria "incontinence" and "urge incontinence", it was not possible to conduct a final balancing of positive and negative effects on the added benefit. Overall, an added benefit of mirabegron is therefore not proven.

Overactive Bladder Muscles Lead to Irritable Bladder

Women and men with an overactive bladder (irritable bladder) have an increased urge to urinate, which they can hardly control or not control at all (incontinence). Having to go to the toilet more often can significantly impair daily life. People with irritable bladder have to get up at night more frequently (nocturia) and can hardly sleep through the night because of this. Women are affected more often than men.

Diagnosing overactive bladder is only possible after other causes such as urinary tract infection, neurological disorders or side effects of drugs have been excluded. Overactive bladder muscles, which contract too often, are considered to be one of the main causes. It is unknown why this happens. Mirabegron aims to relax the muscles of the bladder and relieve the urge to urinate.

G-BA Specifies Appropriate Comparator Therapy

For the treatment of adults with overactive bladder, the G-BA specified seven different drugs as appropriate comparator therapy: darifenacin, fesoterodine, propiverine, solifenacin, tolterodine and trospium chloride. These drugs belong to the group of anticholinergics, which interrupt nerve impulses in the muscles and cause the smooth bladder muscles to relax.

In the manufacturer dossier, mirabegron was compared with tolterodine. Mirabegron is a so called beta 3-adrenoceptor agonist, which activates the corresponding receptors in the muscle cells of the urinary bladder causing the smooth muscles to also relax.

Long-term Data are Essential in Long-term Treatment

IQWiG included one long-term study (179-CL-049) in the assessment, which the manufacturer had reported, but not used to derive an added benefit. As long-term therapy is necessary to treat irritable bladder, this study, with a duration of 12 months and more than 800 patients per study arm, provides the key data for the assessment of mirabegron. The results of four smaller short-term studies with a duration of 12 weeks each were used as additional information for the dossier assessment.

The average age of the mainly white study participants was between 54 and 60 years. The proportion of women was between two thirds and three quarters and therefore considerably larger.

No differences in Mortality, Morbidity and Quality of Life

There were no relevant differences between the treatment groups in severity, frequency and impairments due to the urge to urinate or in the frequency of nocturia. No added benefit of mirabegron could be derived from these results, and there were no data on further decisive aspects of morbidity: The manufacturer dossier provided no results for the total population on incontinence and urge incontinence.

There were also no statistically significant differences between the results with regard to mortality. Moreover, patients who were taking mirabegron did not assess their quality of life differently from the ones who used tolterodine. Hence there were no differences between the treatment groups with regard to these aspects either.

Advantage of Mirabegron in Side Effects

Severe side effects or discontinuations due to side effects, with approximately 5%, were as common under treatment with mirabegron as under treatment with tolterodine. However, patients under mirabegron reported fewer cases of dry mouth. This results in proof of lesser harm in non-serious side effects with the extent "considerable".

Balancing of Added Benefit not Possible

Overall, no added benefit could be derived for mirabegron because it was not possible to conduct a conclusive balancing of positive and negative effects due to the missing data on the outcomes "incontinence" and "urge incontinence". Hence an added benefit of mirabegron versus tolterodine is not proven.

G-BA Decides on the Extent of Added Benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

INFORMATION: An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on mirabegron.

The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of mirabegron.

More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.

ELSE PRESS RELEASES FROM THIS DATE:

Giant garbage patches help redefine ocean boundaries

2014-09-02

WASHINGTON, D.C., September 2, 2014 – The Great Pacific Garbage Patch is an area of environmental concern between Hawaii and California where the ocean surface is marred by scattered pieces of plastic, which outweigh plankton in that part of the ocean and pose risks to fish, turtles and birds that eat the trash. Scientists believe the garbage patch is but one of at least five, each located in the center of large, circular ocean currents called gyres that suck in and trap floating debris. Researchers from the University of New South Wales (UNSW), in Sydney, Australia, ...

New method for non-invasive prostate cancer screening

2014-09-02

WASHINGTON D.C., Sept. 2, 2014 – Cancer screening is a critical approach for preventing cancer deaths because cases caught early are often more treatable. But while there are already existing ways to screen for different types of cancer, there is a great need for even more safe, cheap and effective methods to save even more lives. Now a team of researchers led by Shaoxin Li at Guangdong Medical College in China has demonstrated the potential of a new, non-invasive method to screen for prostate cancer, a common type of cancer in men worldwide. They describe their laboratory ...

Scientists create renewable fossil fuel alternative using bacteria

2014-09-02

The development is a step towards commercial production of a source of fuel that could one day provide an alternative to fossil fuels. Propane is an appealing source of cleaner fuel because it has an existing global market. It is already produced as a by-product during natural gas processing and petroleum refining, but both are finite resources. In its current form it makes up the bulk of LPG (liquid petroleum gas), which is used in many applications, from central heating to camping stoves and conventional motor vehicles. In a new study, the team of scientists from ...

A handsome face could mean lower semen quality

2014-09-02

Contrary to what one might expect, facial masculinity was negatively associated with semen quality in a recent Journal of Evolutionary Biology study. As increased levels of testosterone have been demonstrated to impair sperm production, this finding may indicate a trade-off between investments in secondary sexual signaling (i.e. facial masculinity) and fertility. Interestingly, males estimated facial images generally more attractive than females did, suggesting that males may generally overestimate the attractiveness of other men to females. INFORMATION: END ...

Underwater grass comeback bodes well for Chesapeake Bay

2014-09-02

CAMBRIDGE, MD (September 2, 2014)—The Susquehanna Flats, a large bed of underwater grasses near the mouth of the Susquehanna River, virtually disappeared from the upper Chesapeake Bay after Tropical Storm Agnes more than 40 years ago. However, the grasses mysteriously began to come back in the early 2000s. Today, the bed is one of the biggest and healthiest in the Bay, spanning some 20 square miles. A new study by scientists at the University of Maryland Center for Environmental Science explores what's behind this major comeback. "This is a story about resilience," said ...

Men who exercise less likely to wake up to urinate

2014-09-02

MAYWOOD, Ill – Men who are physically active are at lower risk of nocturia (waking up at night to urinate), according to a study led by a Loyola University Chicago Stritch School of Medicine researcher. The study by Kate Wolin, ScD, and colleagues is published online ahead of print in Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Nocturia is the most common and bothersome lower urinary tract symptom in men. It can be due to an enlarged prostate known as benign prostatic hyperplasia (BPH) -- as the prostate ...

Observing the onset of a magnetic substorm

2014-09-02

Magnetic substorms, the disruptions in geomagnetic activity that cause brightening of aurora, may sometimes be driven by a different process than generally thought, a new study in the Journal of Geophysical Research: Space Physics shows. Hwang et al. report observations using the Cluster spacecraft and ground-based magnetometers associated with the onset of a substorm. They saw two consecutive sudden jumps in the current sheet normal component of the magnetic field in the plasma sheet (the surface of dense plasma that lies approximately in Earth's equatorial plane), separated ...

Researchers uncover hidden infection route of major bacterial pathogen

2014-09-02

Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis. Pseudomonas aeruginosa is usually harmless to humans, but in people with cystic fibrosis (CF) or who have weakened immune systems – such as those who have had an operation or treatment for cancer – it can cause infections that are resistant to antibiotics. In CF patients in particular, infections can be impossible to eradicate from the lungs. The ...

Aging gracefully: Diving seabirds shed light on declines with age

2014-09-02

Scientists who studied long-lived diving birds, which represent valuable models to examine aging in the wild, found that blood oxygen stores, resting metabolism and thyroid hormone levels all declined with age, although diving performance did not. Apparently, physiological changes do occur with age in long-lived species, but they may have no detectable effect on behavioral performance. The Functional Ecology findings suggest that reductions in metabolism with age can be viewed as strategic restraint on the part of individuals who are likely to encounter energy-related ...

Could poor stomach absorption of drugs reduce autism medications' effectiveness?

2014-09-02

Recent research has revealed that many children and adults with autism experience gastrointestinal symptoms and that such symptoms can impact the absorption and availability of medications. Because approximately 35% of people with autism take at least one psychotropic medication to help control their symptoms, the authors of a Journal of Clinical Pharmacology commentary are calling for a formal evaluation of the potential relationship between gastrointestinal symptoms and the effectiveness of autism medications. Alternative modes of drug administration may be needed to ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds